Syncom Formulations (India) Ltd.
BSE: 524470 | Sector: Health care |
NSE: N.A. | ISIN Code: INE312C01025 |
BSE 13:25 | 08 Aug | 8.99 |
-0.01 (-0.11%) |
OPEN
9.00 |
HIGH
9.10 |
LOW
8.90 |
NSE 05:30 | 01 Jan | Syncom Formulations (India) Ltd |
OPEN | 9.00 |
PREVIOUS CLOSE | 9.00 |
VOLUME | 828374 |
52-Week high | 19.49 |
52-Week low | 5.76 |
P/E | 42.81 |
Mkt Cap.(Rs cr) | 845 |
Buy Price | 8.97 |
Buy Qty | 75.00 |
Sell Price | 8.99 |
Sell Qty | 2116.00 |
Syncom Formulations (India) Ltd. (SYNCOMFORMUL) - Net Sales
Market Cap
COMPANY | LATEST(Rs) | CHG | CHG(%) | Net Sales (Rs crore) |
Dr Reddy's Labs | 4227.10 | 71.10 | 1.71 | 14405.20 |
Cipla | 1026.60 | -7.65 | -0.74 | 13091.79 |
Sun Pharma.Inds. | 911.05 | -4.15 | -0.45 | 12803.21 |
Lupin | 666.45 | -1.50 | -0.22 | 11771.67 |
Aurobindo Pharma | 571.15 | 2.60 | 0.46 | 11287.14 |
Divi's Lab. | 3925.00 | 13.95 | 0.36 | 8879.82 |
Alkem Lab | 2969.50 | -142.15 | -4.57 | 8829.81 |
Zydus Lifesci. | 362.40 | 5.20 | 1.46 | 7981.90 |
Glenmark Pharma. | 372.00 | -6.25 | -1.65 | 7567.93 |
Torrent Pharma. | 1558.25 | 2.55 | 0.16 | 6742.32 |
Apollo Hospitals | 4461.00 | 87.80 | 2.01 | 6098.30 |
Ipca Labs. | 1007.05 | -8.10 | -0.80 | 5399.36 |
Alembic Pharma | 667.75 | -4.90 | -0.73 | 5051.44 |
Abbott India | 20350.00 | -45.55 | -0.22 | 4919.27 |
Laurus Labs | 552.00 | 6.75 | 1.24 | 4707.04 |
Gland Pharma | 2318.45 | 57.55 | 2.55 | 3462.88 |
Granules India | 313.15 | 2.20 | 0.71 | 3238.44 |
Glaxosmi. Pharma | 1432.85 | 25.00 | 1.78 | 3217.51 |
Ajanta Pharma | 1272.00 | -6.75 | -0.53 | 3140.64 |
Sanofi India | 6544.85 | 6.05 | 0.09 | 2956.60 |
Quick Links for Syncom Formulations (India):
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices